Literature DB >> 4587142

Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.

E Hawrylko, G B Mackaness.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4587142     DOI： 10.1093/jnci/51.5.1677

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

2.  Immunotherapy: its possible application in the management of large-bowel cancer.

Authors:  G M Mavligit; J U Guttermann; M A Burgess; J F Speer; R C Reed; R C Martin; C M McBride; E M Copeland; E A Gehan; E M Hersh
Journal:  Am J Dig Dis       Date:  1974-11

3.  Inhibition of pulmonary metastases of B16 melanoma with irradiated tumor cells and BCG.

Authors:  J Tai; A Guclu; T Ghose; S Norvell
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Canine migration inhibitory factor: effect of Corynebacterium parvum administration.

Authors:  M S Pineiro; C A Bowles; E C Cutchins; M I Bull
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

5.  The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.

Authors:  R Bomford
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

6.  Adjuvant and mitogenic properties of a supernatant fraction of sonically treated Myobacterium bovis (BCG).

Authors:  L A Baker; T Sharpton; P Minden; P A Campbell
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  The modifying effect of BCG on the immunological induction of T cells.

Authors:  G B Mackaness; P H Lagrange; T Ishibashi
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

8.  The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.

Authors:  H El Kappany; C Chopra; V N Nigam; C A Brailovsky; M Elhilali
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.